In summary, CD137 has the potential to be a natural biomarker for sorting a subset of tumor-specific reactive T cells in vitro, but one also needs to pay attention to possible mechanisms of secretion of dysfunctional cellular effector cytokines by TSTs in different tumor types (Table 1). Here, TNFRSF9 is linked to neoplasm.